The PE Ratio as of December 2025 (TTM) for Zevra Therapeutics, Inc. (ZVRA) is 18.43

According to Zevra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 18.43. This represents a change of -300.88% compared to the average of -9.17 of the last 4 quarters.

Zevra Therapeutics, Inc. (ZVRA) Historical PE Ratio (quarterly & annually)

How has ZVRA PE Ratio performed in the past?

The mean historical PE Ratio of Zevra Therapeutics, Inc. over the last ten years is -5.61. The current 18.43 PE Ratio has changed -32939.71% with respect to the historical average. Over the past ten years (40 quarters), ZVRA's PE Ratio was at its highest in in the June 2021 quarter at 15.07. The PE Ratio was at its lowest in in the September 2021 quarter at -46.70.

Zevra Therapeutics, Inc. (ZVRA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Zevra Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zevra Therapeutics, Inc. (ZVRA) Average PE Ratio

How has ZVRA PE Ratio performed in the past?

The current PE Ratio of Zevra Therapeutics, Inc. (ZVRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zevra Therapeutics, Inc. (ZVRA) PE Ratio vs. Peers

How is ZVRA’s PE Ratio compared to its peers?

Zevra Therapeutics, Inc.’s PE Ratio is greater than Corvus Pharmaceuticals, Inc. (-48.41), greater than Akebia Therapeutics, Inc. (-26.47), greater than Prothena Corporation plc (-2.14), greater than Olema Pharmaceuticals, Inc. (-15.80), greater than Ventyx Biosciences, Inc. (-5.35), greater than Rigel Pharmaceuticals, Inc. (7.54), less than Niagen Bioscience Inc (29.95), greater than REGENXBIO Inc. (-3.77), greater than KalVista Pharmaceuticals, Inc. (-4.32), greater than Gossamer Bio, Inc. (-5.44),

Build a custom stock screener for Zevra Therapeutics, Inc. (ZVRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zevra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zevra Therapeutics, Inc. (ZVRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zevra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.